Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

NCT02574962 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

DRUG: H.P. Acthar® Gel

Sponsor

Mamatha Pasnoor, MD

Collaborators

[object Object]